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Abstract
Background: The degree to which work-related difficulties are recognized in headache research is poor and often
carried out with inadequate information such as “reduced ability to work as usual”, which do not capture at all the
variety of difficulties and the factors that impact over them. The aim of this paper is to present the validation of the
HEADWORK questionnaire, which addresses the amount and severity of difficulties in work-related tasks and the
factors that impact over them.
Methods: We developed a set of items based on a previous literature review and patients’ focus groups and tested
it on a wide set of patients with episodic and chronic migraine attending eight different Italian headache centers.
HEADWORK factor structure was assessed with exploratory and confirmatory factor analysis; internal consistency and
construct validity were addressed as well.
Results: The validation sample (N = 373) was mostly composed of patients with episodic migraine without aura
(64.3%) and of females (81%). Factor analysis retrieved two different scales: “Work-related difficulties”, composed of
eleven items which explain 67.1% of the total variance, and “Factors contributing to work difficulties”, composed of
six items which explain 52.1% of the total variance. Both HEADWORK subscales have good measurement properties,
with higher scores being associated to higher disability, lower quality of life, lower productivity, higher headache
frequency and pain intensity.
Conclusions: HEADWORK is a 17-item, two-scale questionnaire addressing the impact of migraine on work-related
difficulties in terms of difficulties in general or specific skills, and the factors contributing to these difficulties, defined as
negative impact on work tasks. It can be used to address disability weights for the purpose of calculating the burden
of migraine, and to assess the balance between therapeutic and side effects of medication on productivity.
Keywords: Work, Employment, Disability evaluation, Episodic migraine, Chronic migraine, Medication overuse
headache, Validation study
* Correspondence: alberto.raggi@istituto-besta.it
1Neurology, Public Health and Disability Unit, Fondazione IRCCS Istituto
Neurologico Carlo Besta, Milan, Italy
Full list of author information is available at the end of the article
The Journal of Headache
                           and Pain
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Raggi et al. The Journal of Headache and Pain  (2018) 19:85 
https://doi.org/10.1186/s10194-018-0914-7
Background
Episodic Migraine (EM) and Chronic Migraine (CM)
have a considerable impact on patients’ daily lives in
terms of personal suffering, reduced quality of life (QoL)
and disability [1–7], with female and CM sufferers
reporting higher disability [8]. In particular, CM fre-
quently presents with medication overuse headache
(MOH): as shown in some literature findings, an average
of 62.6% (ranging from 50.5% to 68%) of patients with
CM present MOH [9–12] and whether MOH is a conse-
quence or a cause of CM has not been clarified [13].
Migraine disorders determine a considerable burden on
societies, which is usually addressed in terms of reduced
work productivity and cost [14–18]. The most recent
studies on the cost of headache disorders, and of EM
and CM in particular, showed that most of the cost of
such conditions is due to indirect cost, i.e. to reduced
work productivity [14, 15, 19]. When addressing the
issue of indirect cost, two elements have to be acknowl-
edged: the lost workdays (absenteeism) and the work-
days in which people with migraine worked with
reduced productivity (presenteeism). Presenteeism is the
main driver of migraine cost and burden: in fact, for
each lost workday, patients with EM and CM work three
to four days with reduced productivity [20, 21], and the
cost associated to presenteeism is higher than that asso-
ciated to absenteeism [14, 15, 22]. Therefore, addressing
presenteeism in terms of both frequency of days and im-
paired productivity is of importance to measure the bur-
den of EM and CM.
While absenteeism can be addressed with a simple and
direct question, presenteeism may involve difficulties
with the interpretation of content. In fact, the degree to
which migraine headaches impact over work-related
tasks can be highly variable and is underlined by three
elements: a) headache severity, b) the kind of activity or
the multiplicity of activities, that constitute one’s own
job profile, and c) the context in which one’s own job is
carried out. The last two elements may allow the identi-
fication of the different tasks and activities as well of
contextual elements of the job in terms of interpersonal
relationships, and of physical elements that might act as
triggers of migraine headaches. A literature review was
specifically devoted to understanding the degree to which
work-related difficulties are recognized and considered in
headache research [23]. In brief, this review was grounded
on a previous work in which the International Classifica-
tion of Functioning, Disability and Health (ICF) [24] was
used as a term of reference to describe a set of difficulties
that are relevant to migraineurs. Fourteen topics, that
could be referred to difficulties with work-related activ-
ities, were transformed into MESH terms and were used
to search for relevant publications in which these difficul-
ties were experienced by patients with EM, CM, chronic
daily headache or MOH. A total of 23 publications were
selected and the results showed that there was poor recog-
nition of the topic of work-related difficulties, which was
limited to a restricted set of activities such as problem
solving, speaking, driving and on “remunerative employ-
ment”. The latter topic was generally expressed in terms
of reduced ability to “perform job activities” or of reduced
ability to “work as usual”, and the meaning of these defini-
tions was less than clear in available literature. The pres-
ence of contextual elements was a completely neglected
issue.
The main reason for the paucity of information on this
topic is, in our opinion, the lack of patient-reported out-
come measures (PROMs) specifically aimed to capture
the presence, the severity and the type of work-related
difficulties in patients with EM and CM. We therefore
launched an initiative to develop a new questionnaire,
the HEADWORK Questionnaire. Given the paucity of
literature data, we ran a qualitative study with the aim of
exploring which were the most relevant difficulties expe-
rienced by patients with their work activities and which
were the factors that contributed most to these difficul-
ties, getting indications directly from employed patients
with EM and CM. In this qualitative study we ran three
focus groups with 14 patients, that were asked to discuss
the main issues that constitute difficulties with
work-related activities and factors that contributed to
these activities [25]. The results of this qualitative study
showed that 27 were the most relevant themes reported
by patients, and that they referred to: activities (e.g.
reading, writing, speaking), personal factors (e.g. atten-
tion, stress), correlated symptoms (e.g. pain, being numb),
and contextual elements (e.g. office, colleagues, noise,
light). The joint results of the literature review, and of this
qualitative analysis enabled us to define a set of relevant
themes which referred to 13 activities and 12 factors
impacting on these difficulties that were used to develop
the preliminary version of the HEADWORK Question-
naire. The aim of this paper is to validate this new ques-
tionnaire and report its measurement properties.
Methods
Participants
Adult patients, i.e. 18 or older, were enrolled for the val-
idation study between June 2016 and October 2017
among those attending eight different Italian headache
centers. The main inclusion criterion was the clinical
diagnosis of one of the different migraine form according
to the International Classification of Headache Disorders,
3-beta version (ICHD-3Beta) [26], namely EM without
and with aura (i.e. codes 1.1 or 1.2 of the ICHD-3Beta),
and CM, with or without associated MOH (i.e. code 1.3
with or without associated code 8.2 of the ICHD-3Beta).
When available, headache diaries were also used for
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diagnostic purposes. The other inclusion criterion was the
fact of being currently employed (or on sick leave) as main
occupation and being paid for the activity at the time of
enrolment, i.e. no students, retired people or people work-
ing on a voluntary basis were included. Both outpatients
and inpatients were enrolled. Exclusion criteria, evaluated
by the treating neurologist (LG and DD at Fondazione
Istituto Neurologico C. Besta IRCCS; MB and GV at Uni-
versità Politecnica delle Marche; SC and GP at IRCCS Isti-
tuto delle Scienze Neurologiche di Bologna; GT and AR at
University of Campania “Luigi Vanvitelli”; PB and CA at
IRCCS San Raffaele Pisana; CL and LG at Ospedale L.
Sacco, University of Milan; FF and PDF at San Carlo Bor-
romeo Hospital; FB and LR at Magna Graecia University
of Catanzaro) on the basis of patient evaluation and accur-
ate history taking, were the following: a) presence of cog-
nitive impairments hampering protocol completion (e.g.
severe attention deficits); b) anamnesis of cerebrovascular
diseases or brain tumors; c) psychiatric disorders of psych-
otic area; d) other clinical comorbidities in which pain
might be of similar or higher impact on daily activities as
compared to migraine (e.g. rheumatic diseases, low back
pain and other musculoskeletal chronic conditions).
Participation to the study was on a voluntary basis and
all patients were asked to provide written consent before
inclusion. The study was approved by the Ethical Commit-
tees of the coordinating center, Neurological Institute C.
Besta (protocol approval number 07/2016, January 13,
2016) and subsequently ratified by all participating centers
(Università Politecnica delle Marche, Ancona; IRCCS
Istituto delle Scienze Neurologiche di Bologna, Bologna;
University of Campania “Luigi Vanvitelli”, Naples; IRCCS
San Raffaele Pisana, Rome; Luigi Sacco Hospital-Univer-
sity of Milan, Milan; San Carlo Borromeo Hospital, Milan;
Magna Graecia University of Catanzaro, Catanzaro).
Protocol
The protocol included the collection of socio-demographic
data, and the administration of self-reported tools: the
preliminary 25-item version of the HEADWORK question-
naire, the Migraine Disability Assessment schedule (MIDAS)
[27, 28], the World Health Organization 12-items Disability
Assessment Schedule (WHODAS-12) [29], and the Migraine
Specific Quality of Life Questionnaire (MSQ) [30]. The
MIDAS was chosen as it is the most commonly used out-
come measure in headache research and it provides useful
information on days with headache and average pain severity;
the WHODAS-12 was chosen in reason of the approach to
conceptualization of difficulties due to health reason (see also
below) as limitations due to a health condition. Finally, since
we were interested in ascertaining that HEADWORK’s
content was closer to a disability than to a QoL measure, we
decided to rely on the MSQ as it migraine-specific and it is
valid for use both EM and CM [21–23].
In the socio-demographic section, besides common in-
formation on gender, age, marital status and education, a
set of employment-related items were included. Specific-
ally, patients were asked on the overall duration of their
career and duration of their career in the current com-
pany (in case of self-employed, we asked how long they
have been were self-employed), on the amount of weekly
worked hours, on the dimension of the company (1–9,
10–49, 50–249 or 250+ employed people), and on their
current job classification according to the following defi-
nitions: apprentice/consultant, office/manual worker, ex-
ecutive/manager, private practice, other. Finally, patients
were asked to provide – with reference to the last 30 days
– the number of days they did not work due to migraine,
the number of days they worked with reduced ability
due to headache, and they were invited to give an esti-
mate of their overall work performance, expressed as
percentage on a 1–99% scale (of course referred to the
days with reduced ability).
The items tested in this version of the HEADWORK
questionnaire, defined on the basis of the results of the
previous literature review and patients’ input [23, 25]
were revised by a small panel of 12 patients (with both
EM and CM) and 8 clinicians that were asked to judge
the items and report any problematic issues, namely dif-
ficulties in understanding the content of each item. Spe-
cifically, patients were asked to judge if in their opinion
it was possible to misunderstand what was written, and
not if they experienced the phenomenon described in
the different items. None of the items was judged as un-
clear and minor changes were made, in particular: “Solv-
ing organizational problems at work” was rephrased
from the original “Solving work problems” to focus not
on generic outcomes in term of productivity or result of
the job done, but on “procedural” issues, i.e. the way in
which daily problems with the organization of what has to
be done are handled; “Starting a new work task” was
rephrased from the original “Starting to work”, as the first
version was felt as too much generic and could be taken
in a too much broad sense (e.g. starting a work career).
Once items were finalized, they were grouped into two
section. The first section included 13 items addressing
different work tasks and work-related activities. Patients
were asked to report how much of a difficulty they had
with each activity using a five-point response scale, ran-
ging between 1 (no difficulty) and 5 (I cannot do it). Ex-
amples of these items include talking and interacting
with other people, reading and writing abilities. The sec-
ond section included 12 items addressing the factors
that possibly limit patients’ ability with work-related
activities and prevented them to perform these activities.
Patients were invited to answer on a five-point scale (ran-
ging between 1-no limitations, and 5-complete limitation):
examples of these items include negative attitudes of
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colleagues and environmental triggers, such as noise or
smell. For both the section, items had to be answered
thinking back to the last 30 days and. The option “not ap-
plicable” was left in case an activity or a factor was not of
relevance for respondents’ jobs or was not part of the
workplace features. There are different reasons for choos-
ing a 5-point scale. First, odd number of items’ response
enable to use the central value for those cases in which
patients feel a non-mild impact but do not wish to move
closer to the maximum value: as we did not use an “agree
vs. not agree” scale, we did not carry the risk of leaving a
central option meaning “not taking position”. Second, we
preferred the 5-item options as it is easier to fill in
compared to the 7-item one. In fact, in the 7-item option
there are two steps between the lowest (or highest) value
and the central one, which are difficult to label. Third, we
intended to ground our measure on the definition of dis-
ability endorsed by the ICF [24] and operationalized with
the WHODAS i.e. limitation in carrying out daily activities
due to the presence of a health condition. The content of
HEADWORK is close to such a definition, as the activities
that are limited by migraine headaches are work-related
ones.
The MIDAS [27, 28] is composed of seven questions
referred to the preceding three months. The first two
questions investigate the impact of headache on work, in
terms of missed workdays and of work with at least half
reduction, the third and fourth apply the same scheme
to household work, and the fifth addresses missed leis-
ure/family/social activities due to headache. Responses
are given in terms of days with missed or reduced activ-
ities. The sixth question is on the number of days with
headache and the seventh is on average pain intensity.
MIDAS is scored based on the first five question by sim-
ply summing up the days: four severity grades are avail-
able, i.e. minimal (0–5), mild (6–10), moderate (11–20),
and severe (≥21) disability.
The WHODAS-12 is the short version of the original
36-items WHODAS 2.0. It investigates the same do-
mains as the original version (i.e. understanding and
communicating, getting around, self-care, getting along
with people, life activities, and participation in society),
and accounts for 81% of the variation of the original full
questionnaire. Patients are asked to respond to 12 ques-
tions referred to daily activities, and they report how
much of a difficulty they experienced during the previ-
ous 30 days, due to their health condition. Answers have
to be rated on a 5-point scale (no problems – complete
problems/cannot do the activity), and WHODAS-12
score ranges between 0 and 100, with higher scores
reflecting greater disability [29].
The MSQ is a migraine-specific measure of health-re-
lated QoL [30]. The questionnaire is composed of 14
items that form three scales, namely role-restriction (RR),
role-prevention (RP) and emotional function (EF): each
scale has a 0–100 score, with lower scores indicating lower
health-related QoL. Items refer to different daily activities
or social situations, and patients have to rate how fre-
quently migraine determined an impact on these activities,
thinking back to the previous four weeks, using a 6-point
scale from never to always. The MSQ has mostly been
used with patients with EM, but it has also been validated
in those with CM [31, 32].
Data analyses
Continuous variables were reported as means and
standard deviations (SD), categorical variables as fre-
quencies and percentages. Data were analyzed with
SPSS 19.0.
Factor structure and item reduction
The approach to the definition of the HEADWORK
questionnaire’s factor structure involved an exploratory
factor analysis (EFA) on 70% of the sample, followed by
a confirmatory factor analysis (CFA) on the remaining
30% and, later on, on the whole sample.
Prior to carrying out the EFA, we transformed the
“not applicable” items into missing and evaluated sym-
metry indexes: items that were clearly asymmetric (i.e.
with symmetry index ≥2.58) were eliminated from the
dataset. We also looked at the inter-correlation between
items, separately within the two sections of HEAD-
WORK, and removed those items with an overall
inter-item correlation index below .300. We also re-
moved those items that showed correlation indexes
>.800 with at least two other items in each of the two
sections of HEADWORK (i.e. more than 10% of the
total number of items), to avoid, or at least limit, the risk
of multicollinearity or singularity problems [33]. Suit-
ability of data for factor analysis was assessed with
Bartlett’s test of sphericity (BTS), adequate if P < .05
[33], and with Kaiser-Meyer-Olkin Measure of Sampling
Adequacy (KMO), adequate if > 0.70 [33, 34]. EFA was
carried out using principal component extraction and
direct Oblimin rotation to extract data, as we reasonably
expected that, should EFA define more than one factor,
they might have been significantly correlated each other.
Three steps to item reduction were followed. First, we
deleted items that did not load into any factor (i.e. with
factor loadings <.400) as they gave no contribution to
questionnaire’s structure. Second, items loading into
more than one factor (i.e. with factor loadings >.40) were
deleted as they would determine high instability to the
factor structure of the questionnaire. Third, we looked
at scale reliability information, namely inter-item correl-
ation, item-total correlation and Cronbach’s Alpha: we
deleted items that were either too much correlated (i.e.
coefficient > .800) with at least two other items, or that
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showed a low item-total correlation (i.e. coefficient
< .300), or that would make Alpha increase if deleted.
The ratio between Chi2 and degrees of freedom (Chi2/
d.f.) and the Root Mean Square Error of Approximation
(RMSEA) were used as model fit indices for CFA: Chi2/d.f.
< 3 and RMSEA< 0.08 were considered acceptable [34].
Internal consistency
Internal consistency was assessed using Cronbach’s
Alpha coefficient, item-total correlation after correcting
for overlap (i.e. removing the item from the total score),
and the average inter-item correlation. Scales were con-
sidered to have a good reliability if Cronbach’s alpha was
>.70 [35], if item-total correlation indexes were > 0.40,
and if average inter-item correlations were comprised
between 0.30 and 0.70 [36].
Construct validity
Construct validity was tested in different ways. First, by cor-
relating the two HEADWORK scales with WHODAS-12,
MSQ, and MIDAS sores, headache frequency, and average
pain severity in the previous three months, the amount of
lost workdays and of workdays in which productivity was
impaired, and with the estimated average productivity in
days worked with reduced productivity. We used Pearson’s
correlation, and expected that HEADWORK scales: a) were
directly correlated with all the other variables (with the ex-
clusion of MSQ scores, and with the estimated average
productivity, where an inverse correlation is expected), and
with correlation coefficients < .700; b) had a stronger cor-
relation with the WHODAS-12 than with the MSQ scores,
as the construct underlining HEADWORK is the amount
and severity of difficulties with work-related activities; c)
had a stronger correlation with the average pain severity
and the average work ability than with the variables related
to frequency of headache, workdays lost and days worked
with reduced productivity. Significance was set with alpha
= 0.0023 after Bonferroni correction and two-tailed testing.
The second approach to the evaluation of construct
validity, was made by testing the differences in HEAD-
WORK scales between males and females, between pa-
tients with EM and CM, between patients working more
than 40 h/week and those working less, and between pa-
tients employed in medium/large companies and those
employed in small ones. We used Student’s t-test and
expected that females, patients with CM, those working
more than 40 h/week and those employed in larger com-
panies might experience higher difficulties. Significance
was set with alpha = 0.0125 after Bonferroni correction
and two-tailed testing. We also tested HEADWORK
scales across patients with different degrees of education,
and across patients with different types of contract using
One-Way ANOVA and Bonferroni post-hoc test. We ex-
pected that those with lower education and those with
higher-level positions (i.e. employers, private practitioners
or people with executive roles vs. those with temporary
jobs and office/manual workers) might experience higher
difficulties.
For cross-sectional comparisons, Hedges’ g was used
as a measure of effect size (ES): ES around or higher
than 0.5 indicate a medium effect; ES around of higher
than 0.8 indicate a large effect. Data were expressed as
means and 95% Confidence Intervals (95% C.I.).
Results
Sample description
A total of 377 patients were enrolled in the study. However,
four records showed important incompleteness of HEAD-
WORK questionnaire, and further eleven did not have
complete MIDAS, WHODAS-12 or MSQ. Therefore, 373
questionnaires were used to address the factor structure of
HEADWORK, and 362 to address measurement properties.
Table 1 reports the main socio-demographic information of
the validation sample (N = 373). Most of enrolled patients
(280) had EM, and most of them (240) had EM without
aura. The remaining 93 patients had CM, and most of them
(71) had comorbidity to MOH. None of the EM patients
had MOH. On average, it was a highly educated sample, as
41.8% completed university studies and mostly composed
of females (81%). On average, in the previous month pa-
tients with EM lost one day of work and worked 5–7 days
with migraine (approximately with 55–60% of their ability),
while those with CM lost 3–4 days and worked 14–17 days
with migraine (approximately with 50% of their ability).
MIDAS scores, days with headache and WHODAS-12
scores were higher among those with CM than in those
with EM, indicating higher a disability level, while MSQ
scores were lower, indicating a lower quality of life.
Factor analysis
Additional file 1: Tables S1-S4 report the results of
items’ distribution with regard to the amount of not ap-
plicable ones and, after transformation into missing, of
inter-item correlation and asymmetry, as well as the full
inter-item correlation matrix. Among those of the first
section of the preliminary version of HEADWORK, two
items were excluded from the EFA: Managing work
stress, due to high asymmetry; Reaching the workplace
due to high correlation (>.800) with two other items
(Moving from one place to another; Driving a car). From
the second section, five items were deleted as they
showed high asymmetry: Having to work on shifts rota-
tion; Side effect of symptomatic drugs; Side effect of
prophylactic drugs; Feeling dazed/numb; Work stress.
The EFA carried out on 70% of the sample showed
that, for both the first and the second section of the
HEADWORK Questionnaire, a single factor was found:
with regard to the first section, it explained 68.1% of the
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variance of the questionnaire, while for the second sec-
tion it explained 49.9%. The CFA, carried out on the
remaining 30% of the sample confirmed the factor struc-
ture for the first section of HEADWORK, with a similar
amount of explained variance (64.7%) and adequate fit
indices. With regard to the second section, the scale had
an average inter-item correlation that was not satisfac-
tory (.379) and one of the item that was previously in-
cluded (Need to take an excessive amount of
symptomatic drugs) was critical. It showed inadequate
factor loading (.353) and its elimination made Cron-
bach’s Alpha to increase. It was therefore deleted, and
the new CFA showed better fit indices, including a
higher average inter-item correlation (.423) and ex-
plained a higher proportion of variance (53% instead of
47.8%). Additional file 1: Tables S5-S9 show the full fac-
tor structure and the reliability analysis for both sec-
tions, separately for EFA and CFA.
Table 2 reports the results of the factor analysis carried
out over the whole sample. Both sections were com-
posed of one factor, which accounted for 67.1%, and
52.1% of variance, respectively, with good internal
consistency and fit indices. Thus, the first HEADWORK
scale, which we named “Work-related difficulties”, is
composed of eleven items with a theoretical range 11–
55: actually, it ranged between 11 and 53 and its mean
was 31.4 (SD 9.0). The second HEADWORK scale,
which we named “Factors contributing to work difficul-
ties”, is composed of six items with a theoretical range
6–30: actually, it ranged between 6 and 29 and its mean
was 15.8 (SD 5.0).
Construct validity
Table 3 reports the results of correlations between
HEADWORK scales and WHODAS-12, MSQ, MIDAS
scores, headache frequency and average pain severity in
the previous three months, the amount of lost workdays
in the previous month, the amount of workdays in which
productivity was impaired and the estimated average
productivity in those days. All correlations were signifi-
cant, with the exception of the first HEADWORK scale
(Work-related difficulties), and the number of days with
reduced productivity, and all correlations were in the ex-
pected direction. As expected, HEADWORK scales were
more strongly correlated with the WHODAS-12 than
with MIDAS and MSQ scores and also with the average
pain severity and the average work ability rather than
with frequency of headache, workdays lost and days
worked with reduced productivity.
Table 4 reports the results of Student’s t-test in asses-
sing the differences in HEADWORK scales between
males and females, between patients with EM and CM,
between patients working more than 40 h/week and
those working less, and between patients employed in
medium/large companies and those employed in small
ones. Consistently with our expectations, females and
patients with CM showed higher scores at both HEAD-
WORK scales, than males and EM patients, with
medium to large ES. Contrary to our expectations,
people working less than 40 h per week showed higher
scores than those working less only at HEADWORK
“Factors contributing to work difficulties” scale, with a
small ES, while no differences were found for the sub-
scale “Work-related difficulties”. With regard to com-
pany size, the results were in line with our expectation,
but no significant differences were detected. Finally, the








Female gender 224 (80%) 78 (83.9%) 302 (81%)
Age 42.1 ± 10.0 44.0 ± 9.2 42.6 ± 9.8
Education level
Up to secondary 39 (13.9%) 18 (19.4%) 57 (15.3%)
High 109 (52.4%) 51 (54.8%) 160 (42.9%)
University degree or higher 132 (47.1%) 24 (25.8%) 156 (41.8%)
Company size
Small (1–49 employed) 108 (38.7%) 35 (37.6%) 143 (38.3%)
Medium-Large
(50+ employed)
171 (61.1%) 58 (62.4%) 229 (61.7%)
Type of contract
Stage/Other temporary 16 (5.7%) 3 (3.2%) 19 (5.7%)
Office/Manual worker 186 (66.4%) 63 (67.7%) 249 (74.3)
Executive/Manager 9 (3.2%) 5 (5.4%) 14 (4.2%)
Private Practice/Employer 37 (13.2%) 16 (17.2%) 53 (15.8%)
Duration of career 19.1 ± 10.5 21.3 ± 10.9 19.7 ± 10.6
Career in the present company 13.2 ± 9.8 14.1 ± 9.8 13.5 ± 9.8
Weekly worked hours 39.3 ± 10.8 36.9 ± 9.9 38.9 ± 10.6
Workdays lost in the
previous month
1.0 ± 2.0 3.8 ± 6.0 1.7 ± 3.6
Days worked with headache
in the previous month
6.5 ± 5.7 16.8 ± 7.8 8.8 ± 7.6
Average productivity (%) 56.4 ± 23.0 51.6 ± 21.0 55.1 ± 22.7
MIDAS score 27.5 ± 23.8 101.3 ± 60.3 41.8 ± 45.3
Days with headache/3 months 18.9 ± 11.3 61.7 ± 15.6 27.7 ± 21.2
Average pain intensity 7.2 ± 1.7 7.8 ± 1.6 7.3 ± 1.7
WHODAS-12 24.6 ± 17.0 41.2 ± 19.6 28.0 ± 18.7
MSQ-RR 51.6 ± 20.3 30.2 ± 18.9 47.2 ± 21.8
MSQ-RP 65.3 ± 22.0 43.2 ± 22.3 60.8 ± 23.7
MSQ-EF 62.9 ± 27.8 34.4 ± 27.7 57.1 ± 30.0
Notes. EM episodic migraine, CM chronic migraine, MOH medication overuse
headache, MIDAS migraine disability assessment, WHODAS-12 12-items WHO
disability assessment, MSQ migraine specific quality of life questionnaire, RR
role restriction, RP role prevention, EF emotional function
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results of One-Way ANOVA testing HEADWORK
scales across patients with different degrees of education,
and across patients with different types of contract
showed no significant differences, also in this case con-
trary to our expectation.
Discussion
With this paper we present the validation of the HEAD-
WORK questionnaire, a 17-item PROM specifically de-
signed to assess the impact of EM and CM on
work-related tasks and the factors that may contribute
to such difficulties. Our results showed that the different
dimensions regarding the negative influence of migraine
on work activities, i.e. the amount and severity of diffi-
culties in work-related tasks and the factors that impact
over them, can be measured by two distinct scales. The
first scale, named “Work-related difficulties”, is com-
posed of eleven item dealing with the degree to which
migraine headaches determine a difficulty in general
skills, such as solving organizational problems or starting
a new work task, or in specific tasks, e.g. using the com-
puter or talking and interacting with other people. The
Table 2 Factor analysis and reliability data of HEADWORK questionnaire (N = 373)
Loadings Item Mean ± SD Item-Total Correlation Alpha if item excluded
Section A: Work-related difficulties
KMO= .938; BTS, P<.001; Eigenvalue: 7.377 (67.1% of variance)
Alpha= .950; Inter-item R= .636; Average Item-total R= .775
Chi2= 131.2; d.f.= 44; Chi2/d.f.= 2.98; RMSEA=0.047
Paying attention to work tasks .883 2.94 ± 0.97 .851 .942
Solving organizational problems at work .876 2.96 ± 1.04 .832 .943
Starting a new work task .865 2.87 ± 1.03 .818 .943
Dealing with work problems .851 2.95 ± 0.96 .830 .943
Reading and writing .822 2.90 ± 1.05 .784 .945
Using the PC .795 3.13 ± 0.98 .753 .946
Answering the phone .765 2.67 ± 1.01 .754 .946
Driving a car .762 2.81 ± 1.13 .745 .946
Moving from one place to another .760 2.75 ± 1.07 .741 .946
Talking and interacting with other people .756 2.86 ± 0.88 .743 .946
Understanding what is said .684 2.46 ± 0.99 .677 .949
Section B: Factors contributing to work difficulties
KMO = .830; BTS, P < .001; Eigenvalue: 3.127 (52.1% of variance)
Alpha = .808; Inter-item R = .412; Average Item-total R = .570
Chi2 = 20.1; d.f. = 9; Chi2/d.f. = 2.23; RMSEA = 0.050
Noise in the workplace .840 2.94 ± 1.06 .715 .744
Smell in the workplace .767 2.58 ± 1.20 .627 .762
Brightness of workplace .765 2.75 ± 1.07 .676 .752
Extended working hours .652 2.72 ± 1.10 .579 .774
Negative attitudes of colleagues .428 2.17 ± 1.04 .424 .806
Air conditioning .419 2.19 ± 1.15 .400 .809
Notes. KMO Kaiser-Meyer-Olkin Measure of Sampling Adequacy, BTS Bartlett’s Test of Sphericity, d.f. degrees of freedom, RMSEA Root Mean Square Error of
Approximation, SD standard deviation
Table 3 Correlation analysis between HEADWORK scales,
patient-reported outcomes, headache frequency, pain intensity













Average pain severity .367* .301*
N. of lost workdays .256* .206*
N. of days worked with
hampered productivity
.123 .220*
Average productivity −.522* −.342*
Notes. *P < .0023. WHODAS-12 12-items WHO disability assessment, MSQ
migraine specific quality of life questionnaire, RR role restriction, RP role
prevention, EF emotional function, MIDAS migraine disability assessment
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second scale, named “Factors contributing to work diffi-
culties” is composed by six item, and addresses the de-
gree to which some factors, such as noise of brightness
of workplace, or the attitudes of colleagues, negatively
impact on difficulties with work-related tasks. Thus, with
the validation process, we reduced the amount of items
from the initial number of 25 to the final number of 17,
and both HEADWORK subscales showed good meas-
urement properties, with higher scores being associated
to higher impact levels.
The assessment of migraine-related impact on
work-place activities is a relevant research and health-
care topic because migraine is recognized as one of the
most burdensome diseases [37–42]. Of notice, the stud-
ies published on the Global Burden of Disease (GBD)
confirmed that migraine is more prevalent among fe-
males and in both sexes in the most productive age, and
acknowledged migraine as the seventh position in the
rank of top causes of Years Lived with a Disability
(YLDs) in 2010, and then to the sixth in 2013, and even-
tually to the second in 2016 [37–39]. Such an increased
in GBD ranking is likely due to the fact that MOH was
kept distinct from migraine in the first GBD reports,
while in the newly published GBD study, the burden of
MOH was partly assigned to migraine and partly to
tension-type headache, with the result that migraine
ascended to the second rank in the causes of YLD, being
responsible for 5.6% of all YLDs [41]. The reasons for
such a change are shareable, as MOH is a complication
of a pre-existing headache disorder and it does not occur
otherwise [42, 43]. Thus we think that it is correct to as-
sume that there is continuity in terms of disease burden
between EM and CM with MOH, the impact over
work-related tasks being the main domain for negative
impact [44, 45]. Our results are in line with such a hy-
pothesis: HEADWORK scores were higher in CM pa-
tients for both scales, as compared to their episodic
counterpart (with medium to large ES): these findings
can be explained by different aspects characterizing CM
patients, i.e. higher headache frequency, more severe
pain intensity, but mainly the presence of MOH, which
in fact was present in most patients of this group. MOH
is present in more than 60% of CM patients, as shown
by previous literature findings [9–12] and is presumed
to be a concause of CM development [13], but is a dis-
tinct feature as not all CM patients present with MOH.
Mixing primary and secondary headaches may be prob-
lematic but, in our opinion, the problem is mostly taxo-
nomic, as HEADWORK is intended to capture
work-related difficulties due to the presence of EM and
CM, irrespectively from the presence of MOH. It has
also to be noted that the single item of the preliminary
version of our questionnaire addressing MOH (i.e. Need
to take an excessive amount of symptomatic drugs) was
not retained in the final version: so, we believe that
HEADWORK can be used by both the two subgroups of
CM patients, with and without MOH.
HEADWORK is intended to fill in the existing gap on
the measurement and better understanding of reduced
productivity, a task that presents relevant challenges. As
Table 4 Independent sample t-test assessing differences in HEADWORK scales based on gender, migraine type, amount of weekly
worked hours and company size
Variable Mean (95% CI) t-test (P-value) ES
Gender Work-related difficulties Males (N = 71) 27.1 (25.2–29.1) 4.41 (<.001) 0.59
Females (N = 302) 32.3 (31.3–33.4)
Factors contributing to work difficulties Males (N = 71) 12.8 (11.7–13.9) 5.66 (<.001) 0.77
Females (N = 302) 16.5 (15.9–17.0)
Migraine type Work-related difficulties EM (N = 280) 30.5 (29.5–31.6) 3.43 (.001) 0.45
CM (N = 93) 34.5 (32.5–36.5)
Factors contributing to work difficulties EM (N = 280) 15.2 (14.6–15.8) 4.57 (<.001) 0.59
CM (N = 93) 18.1 (17.1–19.0)
Amount of weekly
worked hours
Work-related difficulties Up to 40 h/week (N = 247) 31.7 (30.6–32.9) 1.20 (.23) 0.13
> 40 h/week (N = 115) 30.5 (28.8–32.2)
Factors contributing to work difficulties Up to 40 h/week (N = 247) 16.2 (15.6–16.9) 2.61 (.009) 0.28
> 40 h/week (N = 115) 14.8 (13.9–15.7)
Company size Work-related difficulties Up to 49 employees (N = 143) 30.1 (28.6–31.6) 2.01 (.045) 0.22
50+ employees (N = 229) 32.1 (30.9–33.3)
Factors contributing to work difficulties Up to 49 employees (N = 143) 15.1 (14.3–16.0) 1.78 (.075) 0.20
50+ employees (N = 229) 16.1 (15.4–16.8)
Notes. 95% CI 95% Confidence Interval, EM episodic migraine, CM chronic migraine. Significance set with alpha = 0.0023 after Bonferroni correction
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far as we know, three are the main available instrument
for this task: the Migraine Work and Productivity Loss
Questionnaire (MWPLQ) [46, 47], the MIDAS, and the
Work Productivity and Activity Impairment (WPAI)
[48]. The MWPLQ is the only migraine-specific tool to
assess difficulties in the workplace [46, 47]. It is aimed at
measuring the impact of migraine headache on work, in
terms of hours of work lost or of hours worked with mi-
graine symptoms, which also includes a set of questions
assessing the different activities and influencing factors.
These items included difficulty in getting to work, work-
ing in proximity to environmental triggers of migraine
symptoms, difficulty in handling physical aspects of jobs,
visual tasks, mental aspects, and interpersonal issues at
work. A grading of limitations in each investigated activ-
ity is required, on a 6-point scale, from “no difficulty” to
“so much difficulty couldn’t do at all”. This question-
naire was developed to assess the positive impact of
acute medications: all questions are focused on in the
most recent headache attack, and some of them specific-
ally ask the number of hours missed before and after the
medication was taken. The MIDAS includes two ques-
tions on the number of days with total or partial impair-
ment in work activities experienced in the previous
three months. The question on days with 50% or more
impairment in work activities does not allow to capture
the whole range of possible productivity reduction which
may be lower than 50% [14, 15, 49]. Addressing the full
range of limitation is more relevant than missed work-
days in migraine patients, as it is the main driver of mi-
graine cost and burden [14, 15, 20–22, 45]. Furthermore,
the value of MIDAS seems problematic in those patients
with high frequency migraine and CM, because patients
are likely to approximate responses to MIDAS questions
by multipliers of 5 or 10 [21]. Finally, the WPAI is a gen-
eric instrument addressing the negative impact of differ-
ent diseases on work productivity [48]. Questions of the
WPAI investigate the number of lost working hours and
of hours worked with partial productivity limitations (as
assessed on a 10 point scale) in the past seven days, and
includes two questions inquiring how much did the
underlining health condition affected productivity while
working – as well as it affected other regular daily activ-
ities – on a 10-point scale (from “no effect” to “completely
prevented from working”). A migraine-specific version of
this tool can be found on the developer’s website [50] and
its use has been suggested by recent guidelines for ran-
domized trials in CM [51].
In synthesis, the different available PROMS that can be
used in migraine patients are not comparable to HEAD-
WORK, as none of them systematically enable to address
a set of activities that are relevant to carrying out
work-related tasks. The MWPLQ includes some “qualita-
tive” information on the different types of activities and
on influencing factors in the work-place, and both the
MWPLQ and the WPAI include questions on the degree
of impairment while continuing to perform work activities
with migraine. However, the MWPLQ has the specific aim
to assess difficulties in relation to the use of an acute
medication: therefore, the main focus is the amount of
time with difficulties in productivity before and after the
intake of medication during a single migraine attack. Des-
pite the WPAI was recently used to address the role of
nausea and vomiting in determining the economic burden
of migraines [52] and in a RCT on the anti-CGRP anti-
body fremanezumab in CM (data reported at the 2017
International Headache Congress [53]), it has never been
formally validated for migraine patients to date. Finally,
the time-frame of reference of these questionnaires may
be too long (such as the three-month period for MIDAS
which may determine reporting bias, particularly in CM
patients [21]) or too short (such as the most recent head-
ache episode for MWPLQ, and the previous seven days
for WPAI) in order to assess clinically meaningful data for
epidemiological and outcome research. On the contrary,
the HEADWORK questionnaire is likely to give an appro-
priate insight on the different dimensions of work-place
difficulties in subjects with migraine in a clinical relevant
period of time (one month). It addresses not only the de-
gree of work-related limitations, but also the impact on
specific work tasks, and the evaluation of whole range of
possible degree of impairment (by a scale from “no diffi-
culty” to “I cannot do it”), thus offering an evaluation of
the reduced work productivity while experiencing a mi-
graine episode, which is the most relevant driver of the
total costs of migraine [14, 15, 19]. In reason of these fea-
tures, we recommend it is used as a measure of migraine
impact over work activities, to produce work-related dis-
ability weights in studies evaluating the burden of EM and
CM, and as a secondary outcome measure in clinical
research.
Some of the results we found were expectable and rep-
resent a confirmation of the content of HEADWORK
items. Among these, our study confirmed that women
and CM patients showed a higher difficulties in work ac-
tivities and reported more factors contributing to these
difficulties than men and episodic migraine patients. In
addition to this, the fact that HEADWORK question-
naire showed higher correlation indexes with the
WHODAS-12 than with the MSQ and with the MIDAS,
was expected in consideration of the similarity in the
formulation of item and questionnaire construct.
Other results shed light on the value and novelty of
HEADWORK as a measure of impact on work-related
activities under different aspects. First, the fact that
headaches frequency showed higher correlation with the
scale “Factors contributing to work difficulties” than
with the scale “Work-related difficulties”. Second, the
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fact that headache intensity showed higher correlations
than headache frequency with HEADWORK scales. This
is somehow novel, as one could expect that the presence
of an higher number of headaches is a factor associated
to the presence of more difficulties, while pain intensity
is generally considered as a secondary outcome. Third,
the fact that both HEADWORK scales showed little cor-
relation with the number of lost workdays and with the
number of days worked with reduced productivity. This
aspect constitutes a step forward in the understanding of
migraine impact, because previously used parameters,
such as absenteeism and presenteeism, may provide only
an indirect information on the extent of work-related
difficulties: what cannot be inferred with such indirect
procedures is the extent of reported limitations with ref-
erence to the specificity of the task constituting one’s
own work duty. HEADWORK fills in this gap, and the
little correlation with commonly used indicators, such as
the number of lost workdays and the number of days
worked with reduced productivity, is a proof of the fact
that the content of HEADWORK is not transposable
with them. The strong correlation between the HEAD-
WORK scales and the self-reported productivity in the
days worked with reduced ability is a further confirm-
ation of the unique information produced by HEAD-
WORK questionnaire. In our opinion, all of these
aspects show the ability of HEADWORK to disentangle
the problems due to migraine as a disease – which is ac-
companied by an ensemble of socio-cultural representa-
tion, such as the need to use drugs to function, and
stigma (which is particularly affected by the ability to
work [54]) – and the presence of single headaches,
which may have a “more or less” severe impact depend-
ing on several factors. These factors can be connected to
the subjective response to therapies, but also to the fea-
tures of the context in which the person works, in terms,
for example, of environmental triggers (like noise or
light) or of possibility to quit working or attitudes of
colleagues.
Some limitations have to be acknowledged. Sample
size was wide enough, as showed by KMO and BTS, but
was entirely derived from specialty headache centers: the
primary effect of this was the high presence of patients
with CM (around 25%) compared to what could be ex-
pectable based on the epidemiological presentation of
this condition. Second we did not test the stability of the
questionnaire, i.e. whether few days after the first admin-
istration patients would report similar responses. Simi-
larly, sensitivity to change, i.e. the degree to which
changes in patients’ responses are consistent with
changes in the disease profile, was not addressed as a
longitudinal design would be needed. Such an aspect is
of particular relevance, and might constitute important
information for clinicians and patients in the process of
decision making on the best therapeutic options. In fact,
it will be very interesting to understand what may be the
main drivers of HEADWORK scales change, considering
the potential role of different variables, such as fre-
quency (which is generally considered as the major out-
come measure in headache research – but showed a
modest correlation with HEADWORK scores), or sever-
ity of headaches, but also presence of treatment-related
side effects, particularly such those that may have an im-
portant role on work-place activities and productivity,
such as somnolence, sedation dizziness or fatigue, and
which are relatively common with preventive anti-mi-
graine medications. Third, the questionnaire is not de-
signed to distinguish the impact of migraine on
work-related aspects in ictal and interictal phases as pa-
tients are required to fill in HEADWORK with reference
to the previous 30 days, thus taking into account good
and bad days. Fourth, headache diaries were used when
available, but we do not have track of how many patients
had. Diagnosis was clinical and based on ICHD-3Beta
criteria for EM with and without aura and CM with and
without MOH: however, we cannot exclude mixed diag-
noses, i.e. presence of tension-type headaches, for some
cases. Finally, among the next steps to further on imple-
ment HEADWORK, the definition of cut-off scores is
surely the most relevant one. Further clinical and
labor-related aspects would however be needed to per-
form such a task. Frequency of access to emergency de-
partments, recurrence of relapses into MOH and
presence of comorbidities, that have been showed to
negatively impact on disability and QoL [55], may be
relevant clinical indicators, and presence of disability
benefits and – prospectively – risk of unemployment
may be relevant labour-related indicators for grading of
HEADWORK questionnaire.
Conclusions
We presented the validation of the HEADWORK ques-
tionnaire, a brief questionnaire which addresses the im-
pact of migraine on work-related difficulties in terms of
presence, and severity, of difficulties in general and spe-
cific skills, and it also addresses the factors contributing
to these difficulties, defined as negative impact on work
tasks. It has been validated in patients with episodic and
chronic migraine and it can be used in all populations of
employed persons, either adults or adolescents. HEAD-
WORK is composed of 17 items that are grouped in two
scales, both of them with good measurement properties,
where higher scores reflect the presence of severe diffi-
culties on one side, and of more interfering factors con-
tributing to these difficulties on the other side.
We propose HEADWORK as a feasible way to pro-
duce reliable work-related disability weights in studies
evaluating the burden of episodic and chronic migraine
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in epidemiological and clinical research. Further studies
are needed to prove its role as an outcome tool, and its
ability to assess the balance between therapeutic effects
and side effects of given treatment interventions on
work performance and productivity. Future studies are
also needed to test the validity of HEADWORK in other
headache disorders, such as tension-type headache.
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